Estimates of worldwide burden of cancer in 2008: GLOBOCAN, Int J Cancer, vol.127, pp.2893-917, 2008. ,
The oncosurgery approach to managing liver metastases from colorectal cancer: a multidisciplinary international consensus, The Oncologist, vol.17, pp.1225-1264, 2012. ,
Diagnostic imaging of colorectal liver metastases with CT, MR imaging, FDG PET, and/or FDG PET/CT: a meta-analysis of prospective studies including patients who have not previously undergone treatment, Radiology, vol.257, pp.674-84, 2010. ,
Clinical impact of fluorodeoxyglucose-positron emission tomography scan/ computed tomography in comparison with computed tomography on the detection of colorectal cancer recurrence, Eur J Gastroenterol Hepatol, vol.23, pp.275-81, 2011. ,
Metastatic colorectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up, Ann Oncol, vol.25, issue.3, pp.1-9, 2014. ,
Detection of liver metastases from adenocarcinoma of the colon and pancreas: comparison of mangafodipir trisodium-enhanced liver MRI and wholebody FDG PET, AJR Am J Roentgenol, vol.185, pp.239-285, 2005. ,
Detection of colorectal liver metastases: prospective comparison of contrast enhanced US, multidetector CT, PET/CT, and 1.5 Tesla MR with extracellular and reticulo-endothelial cell specific contrast agents, Abdom Imaging, vol.35, pp.511-532, 2010. ,
Novel radioimmunopharmaceuticals for cancer imaging and therapy, Curr Opin Investig Drugs, vol.9, pp.1302-1318, 2008. ,
A pretargeting system for tumor PET imaging and radioimmunotherapy, Front Pharmacol, vol.6, p.54, 2015. ,
The usefulness of immunohistochemistry in sporadic colorectal cancer, Rom J Morphol Embryol, vol.49, pp.525-560, 2008. ,
Stably tethered multifunctional structures of defined composition made by the dock and lock method for use in cancer targeting, Proc Natl Acad Sci, vol.103, pp.6841-6847, 2006. ,
Multifunctional antibodies by the Dock-andLock method for improved cancer imaging and therapy by pretargeting, J Nucl Med, vol.49, pp.158-63, 2008. ,
Pretargeted immuno-positron emission tomography imaging of carcinoembryonic antigenexpressing tumors with a bispecific antibody and a 68Gaand 18F-labeled hapten peptide in mice with human tumor xenografts, Mol Cancer Ther, vol.9, pp.1019-1046, 2010. ,
Recombinant bispecific monoclonal antibodies prepared by the dock-and-lock strategy for pretargeted radioimmunotherapy, Semin Nucl Med, vol.40, pp.190-203, 2010. ,
Bispecific antibody pretargeting PET (immunoPET) with an 124I-labeled hapten-peptide, J Nucl Med, vol.47, pp.1678-88, 2006. ,
Pretargeting for cancer radioimmunotherapy with bispecific antibodies: role of the bispecific antibody's valency for the tumor target antigen, Bioconjug Chem, vol.13, pp.1054-70, 2002. ,
Anesthesia condition for (18)F-FDG imaging of lung metastasis tumors using small animal PET, Nucl Med Biol, vol.35, pp.143-50, 2008. ,
18 F-FDG PET and PET/CT patient preparation: a review of the literature, J Nucl Med Technol, vol.42, pp.5-13, 2014. ,
Improving the delivery of radionuclides for imaging and therapy of cancer using pretargeting methods, Clin Cancer Res, vol.11, pp.7109-7121, 2005. ,
Antibody pretargeting advances cancer radioimmunodetection and radioimmunotherapy, J Clin Oncol, vol.24, pp.823-857, 2006. ,
, Cancer radioimmunotherapy. Immunotherapy, vol.3, pp.349-70, 2011.
Improvement of radioimmunotherapy using pretargeting, Front Oncol, vol.3, p.159, 2013. ,
Reagents and methods for PET using bispecific antibody pretargeting and 68Ga-radiolabeled bivalent hapten-peptide-chelate conjugates, J Nucl Med, vol.45, pp.30-39, 2004. ,
The intraportal injection model for liver metastasis: advantages of associated bioluminescence to assess tumor growth and influences on tumor uptake of radiolabeled anti-carcinoembryonic antigen antibody, Nucl Med Commun, vol.32, pp.147-54, 2011. ,
The carcinoembryonic antigen (CEA) family: structures, suggested functions and expression in normal and malignant tissues, Semin Cancer Biol, vol.9, pp.67-81, 1999. ,
Development of an imaging-guided CEA-pretargeted radionuclide treatment of advanced colorectal cancer: first clinical results, Br J Cancer, vol.109, pp.934-976, 2013. ,
Pretargeted immuno-PET of CEA-expressing intraperitoneal human colonic tumor xenografts: a new sensitive detection method, EJNMMI Res, vol.2, 2012. ,
Gallium-68 PET: a new frontier in receptor cancer imaging, Anticancer Res, vol.27, pp.4087-94, 2007. ,
,
, Ga-labelled peptides for diagnosis of gastroenteropancreatic NET, Eur J Nucl Med Mol Imaging, vol.39, 2012.
ImmunoPET to help stratify patients for targeted therapies and to improve drug development, Eur J Nucl Med Mol Imaging, vol.43, pp.2166-2174, 2016. ,
URL : https://hal.archives-ouvertes.fr/inserm-01809742
A novel bispecific, trivalent antibody construct for targeting pancreatic carcinoma, Cancer Res, vol.68, pp.4819-4845, 2008. ,
Pretargeted immuno-PET and radioimmunotherapy of prostate cancer with an antiTROP-2 x anti-HSG bispecific antibody, Eur J Nucl Med Mol Imaging, vol.40, pp.1377-83, 2013. ,
Pretargeted radioimmunotherapy of colorectal cancer metastases: models and pharmacokinetics predict influence of the physical and radiochemical properties of the radionuclide, Eur J Nucl Med Mol Imaging, vol.38, pp.2153-64, 2011. ,